Abstract
A series of chromene fused cytosine and uracil were prepared by the condensation of thiourea or carbon disulphide with 2-amino-7,7-dimethyl-5-oxo-4-(substituted phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile. The newly synthesized compounds were characterized by IR, 1H-NMR, Elemental analysis and some representative 13C-NMR and Mass spectra. All the title compounds were evaluated for antitubercular and antimicrobial activities against various mycobacterial, bacterial and fungal strains. Some of the compounds have shown promising antimicrobial and antitubercular activity while others were inactive.
Keywords: Antimicrobial activity, antitubercular activity, chromene, fused cytosine, fused uracil.
Anti-Infective Agents
Title:Design, Synthesis and In Vitro Anti-Mycobacterial Activity of Chromene Fused Cytosine and Uracil Analogues
Volume: 11 Issue: 1
Author(s): Nimesh R. Kamdar, Dhaval D. Haveliwala, Prashant T. Mistry and Saurabh K. Patel
Affiliation:
Keywords: Antimicrobial activity, antitubercular activity, chromene, fused cytosine, fused uracil.
Abstract: A series of chromene fused cytosine and uracil were prepared by the condensation of thiourea or carbon disulphide with 2-amino-7,7-dimethyl-5-oxo-4-(substituted phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile. The newly synthesized compounds were characterized by IR, 1H-NMR, Elemental analysis and some representative 13C-NMR and Mass spectra. All the title compounds were evaluated for antitubercular and antimicrobial activities against various mycobacterial, bacterial and fungal strains. Some of the compounds have shown promising antimicrobial and antitubercular activity while others were inactive.
Export Options
About this article
Cite this article as:
Kamdar R. Nimesh, Haveliwala D. Dhaval, Mistry T. Prashant and Patel K. Saurabh, Design, Synthesis and In Vitro Anti-Mycobacterial Activity of Chromene Fused Cytosine and Uracil Analogues, Anti-Infective Agents 2013; 11 (1) . https://dx.doi.org/10.2174/22113626130105
DOI https://dx.doi.org/10.2174/22113626130105 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Atypical Presentation Of Anti-Retroviral Therapy Induced Lactic Acidosis as Acute Right Ventricular Failure And Severe Pulmonary Hypertension
New Emirates Medical Journal α-Glucan Pathway as a Novel Mtb Drug Target: Structural Insights and Cues for Polypharmcological Targeting of GlgB and GlgE
Current Medicinal Chemistry From new Diagnostic Targets to Recombinant Proteins and Semi-Synthetic Protein-Based Vaccines
Current Organic Chemistry HIV-1 Prophylactic Vaccine Trials in Thailand
Current HIV Research In Vitro Drug Release Behavior, Mechanism and Antimicrobial Activity of Rifampicin Loaded Low Molecular Weight PLGA-PEG-PLGA Triblock Copolymeric Nanospheres
Current Drug Delivery SCYPPred: A Web-Based Predictor of SNPs for Human Cytochrome P450
Protein & Peptide Letters Microwave-Assisted Synthesis and Bioactivities of Novel Quinoline Lactones
Letters in Organic Chemistry The Fabrication and Application of Bio-Functional Microspheres
Current Organic Chemistry The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery Vitamin D and Tuberculosis
Current Respiratory Medicine Reviews Subject Index To Volume 12
Current Pharmaceutical Design Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Medical and Societal Impact
Current Immunology Reviews (Discontinued) Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics Quantification of Rifaximin in Tablets by an Environmentally Friendly Visible Spectrophotometric Method
Current Pharmaceutical Analysis Antibacterial Effects of Carbon Monoxide
Current Pharmaceutical Biotechnology Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active Substrates
Current Drug Discovery Technologies Deep Transfer Learning for COVID-19 Prediction: Case Study for Limited Data Problems
Current Medical Imaging Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application
Current Drug Research Reviews Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB
Recent Patents on Anti-Infective Drug Discovery Structure-and-Mechanism-Based Design and Discovery of Type II Mycobacterium Tuberculosis Dehydroquinate Dehydratase Inhibitors
Current Topics in Medicinal Chemistry